Transcriptional Suppression of the Estrogen Receptor by Truncated Estrogen Receptor-Alpha

Abstract

The estrogen receptor (ER) is composed of six major functional domains - the A/B domain as the activation function 1 domain, domain C as the DNA-binding domain, domain D as a hinge domain, and domain E/F as the ligand-dependent transcriptional domains. A novel protein (designated as SRB-RGS) that interacted with domains C and D of ERα (ERα C/D) repressed the transcriptional activity of ERα. In this study, we have examined whether ERα C/D releases transcriptional suppression of ERα by intrinsic SRB-RGS. The expression vector of ERα C/D was transfected to the human cancer cell, KPL-1, which expressed the intrinsic ER. Unexpectedly, transcriptional suppression of ER by ERα C/D was observed. COS-7 cells, which have no intrinsic ER, showed a similar suppression of ERα by co-transfection of ERα and ERα C/D. The DNA-binding and the estrogen-binding activities of ERα decreased on co-transfection of ERα C/D, suggesting a decrease in the receptor protein itself. It is likely that the degradation of ER by co-transfection caused the transcriptional suppression of the ER.

Dominant Negative - DNA-Binding Domain - SRB-RGS - Degradation - Breast Cancer Cell - COS-7 Cell - Gel-Shift Assay

References

• 1 Evans R M. The steroid and thyroid hormone receptor superfamily.  Science. 1988;  240 889-895
• 2 Freedman L. Increasing the complexity of coactivation in nuclear receptor signaling.  Cell. 1999;  97 5-8
• 3 Muramatsu M, Inoue S. Breakthroughs and views. Estrogen receptors: How do they control reproductive and nonreproductive functions?.  Biochem Biophys Res Commun. 2000;  270 1-10
• 4 Ikeda M, Hirokawa M, Satani N, Kinoshita T, Watanabe Y, Inoue H, Tone S, Ishikawa T, Minatogawa Y. Molecular cloning and characterization of a steroid receptor-binding regulator of G-protein signalling cDNA.  Gene. 2001;  273 207-214
• 5 Nakatani Y. Histone acetylases - versatile players.  Genes Cells. 2001;  6 79-96
• 6 Ince B A, Zhuang Y, Wrenn C K, Shapiro D J, Katzenellebogen B S. Powerful dominant negative mutants of the human estrogen receptor.  J Biol Chem. 1993;  268 14 026-14 032
• 7 Karl M, Lamberts S W, Koper J W, Katz D A, Huizenga N E, Kino T, Haddad B R, Hughes M R. Cushing disease preceded by generalized glucocorticoid resistance:clinical consequences of a novel, dominant negative glucocorticoid receptor mutant.  Proc Assoc Am Physicians. 1996;  108 296-307
• 8 Palvimo J J, Kallio P J, Ikonen T, Mehto M, Janne O A. Dominant negative regulation of trans-activation by the rat androgen receptor: Roles of the N-terminal domain and heterodimer formation.  Mol Endocrinol. 1993;  7 1399-1407
• 9 Tagami T, James J L. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone.  Endocrinology. 1998;  139 640-650
• 10 Schodin D J, Zhuang Y, Shapiro D J, Katzenellebogen B S. Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness.  J Biol Chem. 1995;  270 31 163-31 171
• 11 Wang H, Zeng X, Khan S A. Estrogen receptor variants ERΔ5 and ERΔ7 down-regulate wild-type estrogen receptor activity.  Mol Cell Endocrinol. 1999;  156 159-168
• 12 Kalderon D, Roberts B L, Richardson W D, Smith A E. A short amino acid sequence able to specify nuclear location.  Cell. 1984;  39 499-509
• 13 Wu Y, Tam S-P, Davies P L. A modified CAT expression vector with convenient cloning sites.  Nucleic Acid Res. 1990;  18 1919
• 14 Ikeda M, Ogata F, Curtis S W, Lubahn D B, French F S, Wilson E, Korach K S. Characterization of the DNA-binding domain of the mouse uterine estrogen receptor using site-directed polyclonal antibodies.  J Biol Chem. 1993;  268 10 296-10 302
• 15 Ikeda M, Tsuji N, Kikukawa K, Asahara Y, Nakashima A, Minatogawa Y. DNA-binding properties of the overexpressed recombinant estrogen receptor α.  Biochem Mol Biol Int. 1998;  45 673-680
• 16 Schwabe J W, Chapman L, Finch J T, Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements.  Cell. 1993;  75 567-578
• 17 Fawell S E, Lees J A, White R, Parker M G. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor.  Cell. 1990;  60 953-962
• 18 Sica V, Weisz A, Petrillo A, Armetta I, Puca G A. Assay of total estradiol in tissue homogenate and tissue fractions by exchange with sodium thiocyanate at low temperature.  Biochem. 1981;  20 686-693
• 19 Wang H, Peters G, Zeng X, Tang M, Ip W, Khan S. Yeast two-hybrid system demonstrates that estrogen receptor dimerization is ligand-dependent in vitro.  J Biol Chem. 1995;  270 23 322-23 329
• 20 Abbondanza C, Falco A, Nigro V, Medici N, Armetta I, Molinari A M, Moncharmont B, Puca G A. Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor.  Steroids. 1993;  58 4-12
• 21 Greene G L, Sobel N B, King W J, Jensen E V. Immunochemical studies of estrogen receptors.  J Steroid Biochem. 1984;  20 51-56
• 22 Pratt W B, Toft D O. Steroids receptor interactions with heat shock protein and immunophilin chaperones.  Endocr Rev. 1977;  18 306-360
• 23 Caplan A J. Hsp's secrets unfold: New insights from structural studies.  Trends Cell Biol. 1999;  9 262-268
• 24 Chambraud B, Berry M, Redeuilh G, Chambon P, Baulieu E-M. Several regions of human estrogen receptor are involved in the formation of receptor-heat shock protein 90 complexes.  J Biol Chem. 1990;  265 20 686-20 691